Hypertensive effect of calcilytic NPS 2143 administration in rats

Journal of Endocrinology

Volumn 191, Issue 1, 2006, Pages 189-195

  Rybczynska, Apolonia ^a   Lehmann, Artur ^a   Jurska Jasko, Anna ^a   Boblewski, Konrad ^a   Orlewska, Czeslawa ^a   Folks, Henryk ^a   Drewnowska, Krystyna ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b BOSTWICK LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 [3 [1,1 DIMETHYL 2 (2 NAPHTHYL)ETHYLAMINO] 2 HYDROXYPROPOXY]BENZONITRILE; CALCIMIMETIC AGENT; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; THIOPENTAL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG SYNTHESIS; HORMONE RELEASE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARATHYROID GLAND; PHOSPHATE EXCRETION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; STATISTICAL SIGNIFICANCE; THYROPARATHYROIDECTOMY; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; CALCIUM; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INULIN; MALE; NAPHTHALENES; PARATHYROID HORMONE; PARATHYROIDECTOMY; PHOSPHATES; RATS; RATS, WISTAR; RECEPTORS, CALCIUM-SENSING; TIME FACTORS;

EID: 33751051201     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06924     Document Type: Article

References (35)

1. Arey BJ, Seethala R, Ma Z, Fura A, Morin J, Swartz JA, Vyas V, Yang W, Dicson JK Jr & Feyen JHM 2005 A novel calcium sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo. Endocrinology 146 2015-2022.
2. Baksi SN 1988 Hypotensive action of parathyroid hormone in hypoparathyroid and hyperparathyroid rats. Hypertension 11 509-513.
3. Benishin CG, Lewanczuk RZ & Pang PKT 1991 Purification of parathyroid hypertensive factor from plasma of spontaneously hypertensive rats. PNAS 88 6372-6376.
4. Benishin CG, Lewanczuk RZ, Shan J & Pang PKT 1994 Pang purification and structural characterization of parathyroid hypertensive factor. Journal of Cardiovascular Pharmacology 23 S9-S13
5. 2+ and other ions as extracellular (first) messengers. Physiological Review 71 371-411.
6. Brown EM & MacLeod RJ 2001 Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews 81 239-297.
7. DelMar EG, Barmore RM, Sheehan D, Van Wagen BC, Callahan JF, Keenan RM, Kotecha NR, Lago AM, Southall LS & Thomson M 2003 Calcilytic compounds. United States Patent 6 521 667.
8. Diamond TW, Botha JR, Wing J, Meyers AM & Kalk WJ 1986 Parathyroid hypertension - a reversible disorder. Archives of Internal Medicine 146 1709-1712.
9. Fiske CH & SubbaRow Y 1925 The colorimetric determination of phosphorus. Journal of Biological Chemistry 66 375-400.
10. Fox J, Lowe SH, Conklin RL & Nemeth EF 1999 The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism. Endocrine 10 97-103.
11. Goodman WG, Frazao JM, Goodkin DA, Turner SA, Liu W & Coburn JW 2000 A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney International 58 436-445.
12. Gowen M, Stroup GB, Dodds RA, James IE, Votta BJ, Smith BR, Bhatnagar PK, Lago AM, Callhan JF, DelMar EG et al. 2000 Antaginizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. Journal of Clinical Investigation 105 1595-1604.
13. Jirgensons A, Kauss V Kalvinsh I & Gold MR 2000 A practical synthesis of tert-allcyloamines via the Ritter reaction with chloroacetonitrile. Synthesis 1709-1712.
14. Krylova S, Labedz T, Lewanczuk RZ & Benishin CG 2003 Generation, characterization, and use of monoclonal antibodies against parathyroid hypertensive factor. Clinical Chemistry 49 1204-1206.
15. Lewanczuk RZ & Pang PKT 1990 Vascular and calcemic effects of plasma of spontaneously hypertensive rats. American Journal of Hypertension 3 189S-194S.
16. Lewanczuk RZ, WangJ, Zhang ZR & Pang KT 1989 Effects of spontaneously hypertensive rat plasma on blood pressure and tail artery calcium uptake in normotensive rats. Americanjournal ofHypertension 2 26-31.
17. Lewanczuk RZ, Resnick LM, Ho MS, Benishin CG, Shan J & Pang PKT 1994 Clinical aspects of parathyroid hypertensive factor. Journal of Hypertension 12 11-16.
18. Mann JFE, Wiecek A, Bommer J, Ganten U & Ritz E 1987 Effects of parathyroidectomy on blood pressure in spontaneously hypertensive rats. Nephron 62 465-469.
19. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. Journal of Pharmacology and Experimental Therapeutics 299 323-331.
20. Niederle B, Roka R, Woloszczuk W Klaushofer K, Kovarik J & Schnernthaner G 1987 Successful parathyroidectomy in primary hyperparathyroidism: a clinical follow- up study in 212 consecutive patients. Surgery 102 903-909.
21. Odenwald T, Nakagawa K, Hadtstein Ch, Roesck E Gohlke P Ritz E, Schaefer F & Schmidt CP 2006 Acute blood pressure effects and chronic hypotensive action of calcimimetic in uremic rats. Journal of the American Society of Nephrology 17 662-665.
22. Ohanian J, Gatfield KM, Ward DT & Ohanian V 2005 Evidence for a functional calcium-sensing receptor that modulates myogenic tone in rat subcutaneous small arteries. American Journal of Physiology 288 H1756-Hl762.
23. Onsgaard-Meyer MJ, Berndt TJ, Khraibi AA & Knox FG 1994 Phosphaturic effect of parathyroid hormone in the spontaneously hypertensive rats. American Journal of Physiology 267 R78-R83.
24. Pang PKT, Termer TE Jr, Yee JA & Janssen HF 1980 Hypotensive action of parathyroid hormone preparations on rats and dogs. PNAS 77 675-678.
25. Resnik LM, Muller FB & Laragh JH 1986 Calcium-regulating hormones in essential hypertension. Annals of Internal Medicine 105 649-654.
26. Rybczynska A, Berndt TJ, Hoppe A & Knox FG 1990 Site of restoration of the effect of PTH by propranolol in respiratory alkalosis. Kidney International 8258-262.
27. Rybczynska A, Boblewski K, Lehmann A, Orlewska C, Foks H, Drewnowska K & Hoppe A 2005 Calcimimetic NPS R-568 induces hypotensive effect spontaneously hypertensive rats. American Journal of Hypertension 18 364-371.
28. Saglikes Y, Massry SG, Iseki K, Nadler JL & Campese VM 1985 Effect of PTH on blood pressure and response to vasoconstrictor agonists. American Journal of Physiology 248 F674-F681.
29. Schulter H, Quante C, Buchholz B, Died KH, Spieker C, Karas M & Zidek W 1992 A vasopressor factor partially purified from human parathyroid glands. Biochemical and Biophysical Research Communication 188 323-329.
30. Schuter H, Kluch B, Borjesson-Stoll R, Nordhoff E & Zidek W 1993 Partial purification and characterization of a circulating hypertensive factor in spontaneously hypertensive rats. European Journal of Biochemistry 218 67-73.
31. Silverberg SJ, Bone HG III, Marriott TB, Locker FG, Thys-Jacobs S, Dziem G, Kaatz S, Sangumetti EL & Bilezikian JP 1997 Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with prurnary hyperparathyroidism. New England Journal of Medicine 337 1506-1510.
32. Steffey ME, Fox J, Van Wagenen BC, Delmar EG, Balandrin MF & Nemeth EF 1993 Calcimimetics: structurally and mechanistically novel compounds that inhibit hormone secretion from parathyroid cells. Journal of Bone and Mineral Research 8 S175.
33. 2+ in spontaneously hypertensive rat parathyroid cells. American Journal of Hypertension 17 266-272.
34. Tfelt-Hansen J, Hansen JL, Smajilovic S, Terwillinger EF, Haunso S & Sheikh SP 2006 Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes. American Journal of Physiology 290 H1165-H1171.
35. Ziegelstein RC, Xiong Y, He C & Hu Q 2006 Expression of a functional extracellular calcium-sensing receptor in human aortic endothelial cells. Biochemical and Biophysical Research Communication 342 153-163.